select by year: all years - 2024 - 2023 - 2022 - 2021 - 2020 - 2019 - 2018 - 2017 - 2016 - 2015 - 2014 - 2013 - 2012 - 2011 - 2010 - 2009 - 2008 - 2007 - 2006 - 2005 - 2004 - 2003 - 2002 - 1997

select by group: all groups - Sattler - Tetko - Niessing - Reif - Hagn - Zeidler - Popowicz - Alderson

Pradhan T, Annamalai K, Sarkar R, Huhn S, Hegenbart U, Schönland S, Fändrich M, Reif B (2020)
Seeded fibrils of the germline variant of human λ-III immunoglobulin light chain FOR005 have a similar core as patient fibrils with reduced stability.
The Journal of biological chemistry, Issue 52, Vol. 295, 18474-18484
DOI: 10.1074/jbc.RA120.016006, PubMed: 33093170

Weber B, Hora M, Kazman P, Pradhan T, Rührnößl F, Reif B, Buchner J (2020)
Domain Interactions Determine the Amyloidogenicity of Antibody Light Chain Mutants.
Journal of molecular biology, Issue 23, Vol. 432, 6187-6199
DOI: 10.1016/j.jmb.2020.10.005, PubMed: 33058870

Niu Z, Sarkar R, Aichler M, Wester HJ, Yousefi BH, Reif B (2020)
Mapping the Binding Interface of PET Tracer Molecules and Alzheimer Disease Aβ Fibrils by Using MAS Solid-State NMR Spectroscopy.
Chembiochem : a European journal of chemical biology, Issue 17, Vol. 21, 2495-2502
DOI: 10.1002/cbic.202000143, PubMed: 32291951

Niu Z, Prade E, Malideli E, Hille K, Jussupow A, Mideksa YG, Yan LM, Qian C, Fleisch M, Messias AC, Sarkar R, Sattler M, Lamb DC, Feige MJ, Camilloni C, Kapurniotu A, Reif B (2020)
Structural Insight into IAPP-Derived Amyloid Inhibitors and Their Mechanism of Action.
Angewandte Chemie (International ed. in English), Issue 14, Vol. 59, 5771-5781
DOI: 10.1002/anie.201914559, PubMed: 31863711

Göbl C, Morris VK, van Dam L, Visscher M, Polderman PE, Hartlmüller C, de Ruiter H, Hora M, Liesinger L, Birner-Gruenberger R, Vos HR, Reif B, Madl T, Dansen TB (2020)
Cysteine oxidation triggers amyloid fibril formation of the tumor suppressor p16INK4A.
Redox biology, Vol. 28, 101316
DOI: 10.1016/j.redox.2019.101316, PubMed: 31539802